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an ultrasonicdimension intravascular catheter developed in our institution
(Circulation 1995; 92: 2210-9) and aortic Ps were recorded at the same
point with a Millar catheter (fig. C). The P-D loop changed significantly with
IABC (baseline: fig. A, during IABC: fig. B). Moreover,aortic distensibility (=2
[pulsatile change inaorticD]/[diastolicaortic D] x [pulse P]) increased during
the assisted cycles compared with baseline (3.36 + 1.46 vs. 3.03 * 1.32
10-E.cm2.dyn-1 respectively, p < 0.05).
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Aortic elastic properties appear to improve during IABC. This new method
of determination of theaortic P-D relation, may provide a better understanding
of circulatory physiology during IABC and thus help optimize the application
of IABC.
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H1015122 Improvementof DiaatolicLeftVentricularFunctionbv DobutamineieAssociatedwiththe
Presenceif ViableMyocardiuminPatientswith
IechemicCardiomyopathy
G.A. Somsen, P.A.van der Wouw, A.C. Brauns, P.A.R.de Milliano. Dept. of
Cardiolog~ Academic Medical Centre Amsterdam, the Netherlands,
Ziekenhuis Hilversum, Hilveraum, the Netherlands
Theuseof Iowdoeedobutamine stress echocardiographytodetectviable my-
ccardium has important therapeutical implications in patients with ischemic
cardiomyopathy (lCM). Whether local effects of dobutamine are associated
with global alterations of ventricular function ICM patients has never been
established. Therefore, the effect of dobutamine on ventricular systolic and
diastolic function was related to the Presenceof myocardial viability.
Methods: In 20 stable, ICM patients (NYHA class II and Ill, mean ejec-
tion fraction (EF): 0.27 & 0.10), =-3 months after myocerdial infarction, low
dose (10 @kg/rein) dobutamine achocerdiogrephy was performed. Viabil-
ity was defined as akinetic or hypokinetic segments becoming normokinetic
with systolic wall thickening. At baseline and during maximal dose, pulsed
doppler achocardiography (peak E and A-wave velocity) and nuclear ven-
trfculography (EF, peak filling rate (PFR) and peak election rate (PER) was
performed.
Visbilltypresent(n= 11) Visbilityabsent(n= 9)
baseline dobutamine p bsseline dobutemine p
E (Ink) 0.49+0.11 0.55+0.14 ns 0.53+0.18 0.50+0.18 ns
A(KJs) 0.52&0.14 0.60&0.17 0.05 0,54+ 0.21 0.55* 0.17 ns
EIA 1.03+0.60 1.11+0.61 ns 1.26+0.97 1.11+ 1.05 ns
EF(“A) 29*9 40+ 14 0,001 25+ 12 33* 12 0.09
PFR 1.46+0.67 2.36+ 1.09 0.001 1.19+0.55 1.62+0.76 ns
PER 1.70+0.57 2.87+ 1.21 0.002 1.43* 0.70 1,95l 0.65 0,03
(h4asrr*SD,PFR:enddiastolievolumela,PER:endsystolicvolumela).B aalinevariablaa
didnotdillerbelweenthetwogroupa.
Conclusion: Although, global systolic ventricular function (EF, PER) im-
proved in both groups, diastolic function (A, PFR) exclusively improved in
ICM patients with myocardial viability, indicating recratable myocardial com-
pliance by dobutamine in these patients.
WI A.atyl.h.line-lnduced Epicardial Coronary
Vaaoconatriction Linka with the Degrea of
Microvascular Dysfunction in Dilated
Cardiomyopathy
A. Hirosaka, T. Ishihata, M. Igarashi, N. Komatsu, K. Maehara,
Y. Maruyama, Fukushima Medical College, Fukushima, Japan
The purpose is to investigate whether the vasoconstrictive responses of epi-
cardial coronary artery (EA) to acetylcholine (ACH) links with the degree of
microvascular dysfunction in dilated cardiomyopathy (DCM). SuLr@cfsand
Methods.’Ten DCM patients(EF; 33 + 8%) were studied.Vasoconstrictive
responsesof EA to ACH administration;20, 50 and 100 ~g into the left
coronatyartery were assessedby quantitativecoronaryangiography.The
degreeof the EA constriction was expressad as% changes to the EA diam-
eter after .isosorbide-dinitrate administration. To evaluate the responses of
microcirculation, FloWire was placed in the proximal left anterior descending
coronaty artery (LAD) and the averaged peak flow velocity (APV) waa contin-
uously recorded during the intervention. Coronary microvascular responsee
were determined by intrscoronary injecting drugs in order of ACH 50 Mgand
papsverine (PAP) 10 mg following vasodilation of the EA due to the admin-
istration of nitroglycerin 0.2 mg. Maximal corona~ flow (Flow) of LAD after
each injection was calculated according to the formula; Flow = max-APV x
(coronary crosssectional area) x 0.3,
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Resu/ts;Bothths maximumFlowsafterACH and PAPshowadsignificant
negativecorrelationswiththedegreeof EA-inducedconstrictionrespectively,
as shownin the figure. Hemodynamicparameters(cardiac index, ejection
fraction,left ventricularend-diastolicpressure) did not correlate with the
degreeof EA constriction.Conclusions: In DCM, EA endothelial dysfunction
would progress in a ,parallelfashionlywith the degree of endothelialand
non-endothelialdysfunctionin microvascularbed.
11015-I24I DoesCardiacFtu@ural?epresentaHemorrhagic
ComplicationofThrombolyticTherapyand
ThrombinInhibition?
R.C. Becker,J. Hochman, F. Spencer, C.P.Cannon, M. Burns, S.P. Ball,
E. Antman, for the TIMI 9B Investigators University of Massachusetts
Medical School Worcester MA, USA
An association between thrombin inhibition, intensity of systemic anticoagu-
Iationand the occurrenceof cardiac rupture (CR) has been suggested but not
proven. In TIMI 9B, 3,002 patients with Ml received thrombolytic therapy, as-
pirin and either heparin or the direct thrombin antagonist hirudin. Adiagnoeis
of CR was made in 49 (1.6%) patients with a majority of events taking place
within the initial 24-46 hours. The overall incidence, timing, and proportion of
in-hospital deaths attributable to CR did not differ between treatment groups.
By multivariable analysis, age >70 yr (OR 4.96); p = 0.001 and female sex
(OR 3.59); p = 0.001 were independent predictors of CR. There was a trend
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